Type 2 diabetic patients instructed to walk 10,000 steps per day increased HDL-C and resting energy expenditure and reduced plasminogen-activator inhibitor 1.

PMID: 

Metabolism. 2006 Oct ;55(10):1382-7. PMID: 16979410

Abstract Title: 

Efficacy of a pedometer-based physical activity program on parameters of diabetes control in type 2 diabetes mellitus.

Abstract: 

The aim of the study was to determine whether a recommendation to walk 10000 steps per day would result in significant improvements in glycemic control, insulin sensitivity, and cardiovascular risk in patients with type 2 diabetes mellitus. The study was a 6-week randomized controlled trial that included 30 patients with type 2 diabetes mellitus. After 10 days of baseline activity, patients were randomized into 2 groups: control and active. The control group (n = 15) was instructed to continue with their baseline activity for 6 weeks. The active group (n = 15) was instructed to walk at least 10000 steps per day 5 or more days per week, for 6 weeks. Data relevant to glycemic control and other parameters of health were collected at study weeks 0 and 6. There were no differences in the baseline activity between groups (P = .36). Subjects in the active group significantly increased physical activity by 69% during the intervention phase of the study (P = .002), whereas there was no change in the physical activity of the control group (P>.05). High-density lipoprotein cholesterol and resting energy expenditure significantly increased in the active group (P

read more